Not Signed In - New Results From The ESPRIT Trial Confirm That Dipyridamole Plus Aspirin Is The Treatment Of Choice For Preventing Recurrent Stroke
Mon, 29 Jan 2007 08:00 AM EST
... The latest results from ESPRIT (European/Australasian Stroke Prevention in Reversible Ischaemia Trial), published in the February 2007 issue of Lancet Neurology, confirm that the combination of dipyridamole plus aspirin is the treatment of choice for secondary stroke prevention in patients with stroke of arterial origin. [click link for full article] ...
Related Topics
- Clinical Trials
- Stroke
- Dipyridamole
- Mini-Strokes
- Endometriosis
- Aspirin and Extended-Release Dipyridamole
- Bacterial Vaginosis
- Spasticity
- Aspirin
- Miscarriage
- Gay and Lesbian Health
- Brain injury that results in physical, emotional, or intellectual changes or deficits
- Aphasia
- Dipyridamole Injection
- Aspirin and Carisoprodol
- Treatment
- Abortion
- Treatments
- Syringomyelia
- Pancreatic Cancer
email this page
print this page
bookmark this page
feedback on this page
